Skip to content

Common techniques for studying the biological mechanisms of Chinese medicine prescriptions and syndromes based on multi omics

Common techniques for studying the biological mechanisms of Chinese medicine prescriptions and syndromes based on multi omics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025000777
Enrollment
Unknown
Registered
2025-04-17
Start date
2024-07-11
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Deficiency

Interventions

Observation group:Normal daily diet and drinking water should be avoided and spicy greasy and irritating foods should be avoided.
Control group:Normal daily diet and drinking water should be avoided and spicy greasy and irritating foods should be avoided.

Sponsors

First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for blood deficiency syndrome. (2) Those who are involved in traditional Chinese and Western medicine diseases should meet the diagnostic criteria of traditional Chinese and Western medicine diseases. (3) Determine the age range of participants based on the purpose of each clinical trial and the characteristics of the disease. (4) The person who signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the diagnostic criteria for blood deficiency syndrome. (2) Cases that are not within the scope of drug action. (3) There are obvious overlapping or merging certificates. (4) Breastfeeding or pregnant women. (5) Patients with severe primary diseases such as cardiovascular cerebrovascular liver and kidney diseases as well as psychiatric disorders. (6) Allergic constitution and individuals who are allergic to multiple medications. (7) Those with critical illness and difficulty in accurately evaluating the effectiveness and safety of new drugs

Design outcomes

Primary

MeasureTime frame
Routine blood test;

Secondary

MeasureTime frame
Research on blood and urine biomarkers in patients with blood deficiency syndrome based on multi omics;Routine urine test;Biochemical comprehensive results;

Countries

China

Contacts

Public ContactWangjinhuan

The First Affiliated Hospital of Heilongjiang University of Chinese Medicine

gancaosuan@163.com133339512688

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026